Telesis Bio Inc. TBIO
0.00
(0.01)
(100.00%)
as of 25 Sep
- Market cap
- $5.3M
- P/E
- 0.0×
Follow TBIO
Growth Flags
show if company had growth for consecutive years
| Dec '23 | Dec '22 | Dec '21 | Dec '20 | Jan '20 | Dec '19 | Jan '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
0.43 | 1.40 | 17.83 | 13.80 | 13.80 | 13.80 | 13.80 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(1.61) | (6.80) | (15.83) | (18.79) | (18.79) | (18.79) | (18.79) | — |
P/B ratio |
49.44 | 0.82 | 2.17 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.00 | 1.29 | 2.66 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
(0.08) | 0.52 | 11.61 | 19.27 | 19.27 | 19.27 | 19.27 | — |
EV/EBITDA |
0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
0.06 | (0.37) | (3.49) | (6.55) | (6.55) | (6.55) | (6.55) | — |
EV/FCF |
0.06 | (0.33) | (3.33) | (6.45) | (6.45) | (6.45) | (6.45) | — |
Quick Ratio |
3.09 | 3.67 | 8.88 | 2.80 | 2.80 | 17.79 | 17.79 | — |
Current Ratio |
3.71 | 4.08 | 9.57 | 3.05 | 3.05 | 18.25 | 18.25 | — |
Net Debt/EBITDA |
0.46 | 0.56 | 2.06 | 0.69 | (2.27) | (2.38) | (2.38) | — |
Debt/Assets |
7.69% | 24.19% | 12.12% | 12.78% | 175.86% | 112.70% | 112.70% | 0.00% |
Debt/Equity |
22.76 | 0.42 | 0.16 | (0.13) | (1.86) | (5.82) | (5.82) | — |
Asset Turnover |
0.36 | 0.28 | 0.15 | 0.24 | 0.20 | 0.12 | 0.25 | — |
Operating CF/Net income |
0.71 | 0.80 | 0.94 | 0.85 | 0.83 | 0.77 | 0.77 | — |
Capex/Depreciation |
(0.12) | (1.33) | (0.90) | (0.12) | 0.00 | 0.00 | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (209.49%) | (70.58%) | (119.27%) | 70.74% | 109.28% | 110.65% | 110.65% | — | |
| (64.60%) | (49.05%) | (54.44%) | (67.04%) | (54.89%) | (21.42%) | (42.84%) | — | |
ROIC |
0.00% | (129.18%) | (100.19%) | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(166.37%) | (100.03%) | (44.83%) | (147.08%) | (117.44%) | (27.13%) | (27.13%) | — |
Average Days of Receivables |
79.41 | 77.84 | 121.14 | 125.77 | 125.77 | 113.34 | 113.34 | — |
Research and Development Expense of Revenue |
63.60% | 85.51% | 131.00% | 135.72% | 55.12% | 27.43% | 27.43% | — |
Selling, General and Administrative Expense of Revenue |
125.79% | 140.77% | 228.26% | 168.20% | 32.51% | 32.76% | 32.76% | — |
Intangible Assets out of Total Assets |
0.07 | 0.21 | 0.14 | 0.22 | 0.22 | 0.16 | 0.16 | 0.00 |
Share Based Compensation of Revenue |
14.41% | 13.58% | 9.83% | 0.65% | 0.00% | 0.00% | 0.00% | — |
Graham Net Nets |
(3.38) | 0.53 | 0.34 | 0.23 | 0.23 | 0.23 | 0.23 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(413.49%) | (126.82%) | (30.19%) | (17.01%) | (17.01%) | (17.01%) | (17.01%) | — |
Free Cash Flow Yield |
(311.30%) | (112.66%) | (19.57%) | (21.64%) | (21.64%) | (21.64%) | (21.64%) | — |
Revenue per Share |
16.57 | 16.75 | 10.90 | 23.65 | 0.00 | 0.16 | 0.00 | — |
Operating CF per Share |
(20.89) | (23.63) | (36.22) | (55.31) | 0.00 | (0.22) | 0.00 | — |
Capex per Share |
(1.18) | (2.73) | (1.83) | (0.73) | 0.00 | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(22.07) | (26.36) | (38.05) | (56.04) | 0.00 | (0.22) | 0.00 | — |
Cash per Share |
11.65 | 26.71 | 81.74 | 48.41 | 0.00 | 1.00 | 0.00 | — |
Shareholders Equity per Share |
0.14 | 28.43 | 89.61 | (91.55) | 0.00 | (0.26) | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.14 | 28.43 | 89.61 | (91.55) | 0.00 | (0.26) | 0.00 | — |
Free Cash Flow |
(36.63) | (43.18) | (38.55) | (15.58) | (14.88) | (6.39) | (6.39) | — |
Working Capital |
22.17 | 41.59 | 83.45 | 11.56 | 11.56 | 29.71 | 29.71 | — |
Capital Expenditures |
(1.96) | (4.47) | (1.85) | (0.20) | (0.20) | (0.08) | (0.08) | — |
Net Current Asset Value |
(39.82) | 20.30 | 67.71 | (35.14) | (35.14) | (14.83) | (14.83) | — |
EV/EBIT |
0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.07 | 0.16 | 0.17 | 0.03 | 0.00 | 0.00 | 0.00 | — |
Net Profit Margin |
(178.21%) | (176.68%) | (352.78%) | (273.87%) | (273.87%) | (172.78%) | (172.78%) | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
2.23 | 0.49 | 0.59 | 2.53 | 0.39 | 0.97 | 0.97 | — |
Cash ROIC |
(167.96%) | (41.43%) | (21.40%) | 187.69% | (52.95%) | (11.14%) | (11.14%) | — |
Accounts Receivable Turnover |
4.65 | 5.77 | 3.72 | 2.90 | 3.50 | 3.22 | 3.22 | — |
Accounts Payable Turnover |
4.61 | 6.24 | 3.66 | 1.56 | 10.70 | 12.18 | 12.18 | — |
Inventory Turnover |
3.39 | 5.18 | 4.54 | 4.50 | 24.12 | 8.28 | 8.28 | — |
Average Days of Payables |
113.52 | 39.92 | 135.25 | 147.31 | 55.15 | 25.21 | 34.74 | — |
Days of Inventory on Hand |
139.13 | 67.82 | 128.16 | 74.34 | 15.13 | 29.24 | 58.92 | — |
Average Receivables |
5.92 | 4.76 | 2.97 | 2.27 | 1.88 | 1.49 | 1.49 | — |
Average Payables |
2.29 | 1.90 | 1.85 | 1.89 | 1.60 | 0.73 | 0.73 | — |
Average Inventory |
3.11 | 2.28 | 1.48 | 0.66 | 0.71 | 1.07 | 1.07 | — |
Average Assets |
75.89 | 98.81 | 71.56 | 26.86 | 32.81 | 38.76 | 19.38 | — |
Average Common Equity |
23.40 | 68.67 | 32.66 | (25.46) | (16.48) | (7.50) | (7.50) | — |
Columns are period end dates